Studies have demonstrated the utility of [68Ga]Ga-PSMA PET/CT in differentiating malignant adrenal metastases from benign lesions, such as adrenal adenomas, based on various parameters, such as SUVmax values and lesion morphology [12,13,14,15]. The gene discussed is FOLH1; the disease is adrenal cortex adenoma.